Fractyl Health (GUTS) Debt to Equity (2023 - 2026)

Fractyl Health (GUTS) reported Debt to Equity of $1.41 for Q1 2026, down 69.42% year-on-year from $4.61 in Q1 2025, and down 56.41% quarter-over-quarter from $3.23 in Q4 2025.

Fractyl Health (GUTS) has 4 years of Debt to Equity data on file, last reported at $1.41 in Q1 2026.

  • For the quarter ending Q1 2026, Debt to Equity fell 69.42% year-over-year to $1.41; the trailing twelve-month figure through Mar 2026 stood at $1.41 (down 69.42% YoY), and the FY2025 full-year result was $3.23, up 204.75% from the prior year.
  • Debt to Equity for Q1 2026 stood at $1.41, down from $3.23 in the prior quarter.
  • Across five years, Debt to Equity topped out at $4.61 in Q1 2025 and bottomed at -$9.68 in Q3 2025.
  • A 4-year average of $0.02 and a median of $0.5 in 2024 frame the typical range for Debt to Equity.
  • Peak annual rise in Debt to Equity reached 1252.19% in 2025, while the deepest fall reached 1707.11% in 2025.
  • Tracing GUTS's Debt to Equity over 4 years: stood at -$0.17 in 2023, then surged by 725.43% to $1.06 in 2024, then soared by 204.75% to $3.23 in 2025, then sank by 56.41% to $1.41 in 2026.
  • According to Business Quant data, Debt to Equity over the past three periods registered $1.41, $3.23, and -$9.68 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - -
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 0.06
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn -
10 Fractyl Health 19.24 Mn 19.24 Mn - 1.41

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.41
Dec 31, 2025 3.23
Sep 30, 2025 -9.68
Jun 30, 2025 -1.65
Mar 31, 2025 4.61
Dec 31, 2024 1.06
Sep 30, 2024 0.60
Jun 30, 2024 0.40
Mar 31, 2024 0.34
Dec 31, 2023 -0.17